CytomX Therapeutics
Price & Volume
Stats
See more52W Range | $0.83-$5.85 |
Market Cap | $88.4M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $126.6M |
Revenue Growth (YoY) | 26.7% |
Gross Profit (12 Mos) | $53.1M |
Diluted EPS | $0.16 |
News
See moreYahoo Finance • last year
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
CytomX Therapeutics to Present at Upcoming November Investor Conferences
About
CEO | Dr. Sean A. McCarthy DPHIL |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 120 |
